NasdaqCM - Delayed Quote USD

Revelation Biosciences, Inc. (REVB)

2.0900 +0.0200 (+0.97%)
At close: April 24 at 4:00 PM EDT
2.0500 -0.04 (-1.91%)
After hours: April 24 at 5:28 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
8,656.6640
8,656.6640
10,864.5110
11,950.4850
Operating Income
-8,656.6640
-8,656.6640
-10,864.5110
-11,950.4850
Other Income Expense
8,536.4100
8,536.4100
34.9620
-36.3520
Pretax Income
-120.2540
-120.2540
-10,829.5490
-11,986.8370
Net Income Common Stockholders
-120.2540
-120.2540
-10,829.5490
-11,986.8370
Diluted NI Available to Com Stockholders
-120.2540
-120.2540
-10,829.5490
-11,986.8370
Basic EPS
-0.53
--
-149.20
-972.41
Diluted EPS
-0.53
--
-149.20
-972.41
Basic Average Shares
228.6400
--
72.5850
12.3270
Diluted Average Shares
228.6400
--
72.5850
12.3270
Total Operating Income as Reported
-8,656.6640
-8,656.6640
-10,864.5110
-11,950.4850
Total Expenses
8,656.6640
8,656.6640
10,864.5110
11,950.4850
Net Income from Continuing & Discontinued Operation
-120.2540
-120.2540
-10,829.5490
-11,986.8370
Normalized Income
-8,449.1910
-8,449.1910
-10,829.5490
-11,986.8370
EBIT
-8,656.6640
-8,656.6640
-10,864.5110
-11,950.4850
EBITDA
-8,631.6150
-8,631.6150
-10,839.4630
-11,933.7030
Reconciled Depreciation
25.0490
25.0490
25.0480
16.7820
Net Income from Continuing Operation Net Minority Interest
-120.2540
-120.2540
-10,829.5490
-11,986.8370
Total Unusual Items Excluding Goodwill
8,328.9370
8,328.9370
--
--
Total Unusual Items
8,328.9370
8,328.9370
--
--
Normalized EBITDA
-16,960.5520
-16,960.5520
-10,839.4630
-11,933.7030
12/31/2021 - 11/17/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VRAX Virax Biolabs Group Limited
0.6636
+0.85%
 
MEIP MEI Pharma, Inc.
3.2600
-5.51%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6321
-5.30%
 
ENSC Ensysce Biosciences, Inc.
0.5586
-1.48%
 
KPRX Kiora Pharmaceuticals, Inc.
0.5058
-12.72%
 
TCON TRACON Pharmaceuticals, Inc.
1.8900
+2.16%
 
RNAZ TransCode Therapeutics, Inc.
0.4399
-4.35%
 
TCBP TC Biopharm (Holdings) Plc
1.4700
-6.96%
 
TENX Tenax Therapeutics, Inc.
3.5600
+0.85%
 
FWBI First Wave BioPharma, Inc.
3.0200
-3.21%